| 2024-05-22 |
[Comment] Perfluoroalkyl and polyfluoroalkyl substances: the price of forever chemicals |
Dana L Sheinhaus, Andrea C Gore |
|
| 2024-05-22 |
[Personal View] Small Island Developing States: addressing the intersecting challenges of non-communicable diseases, food insecurity, and climate change |
Cornelia Guell, Arlette Saint Ville, Simon G Anderson, Madhuvanti M Murphy, Viliamu Iese, Sashi Kiran, Gordon M Hickey, Nigel Unwin |
|
| 2024-05-22 |
[Editorial] Sleep: a neglected public health issue |
The Lancet Diabetes & Endocrinology |
|
| 2024-05-22 |
[Review] Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review |
Moath S Alsaqaaby, Sarah Cooney, Carel W le Roux, Dimitri J Pournaras |
|
| 2024-05-22 |
[Correspondence] Effect of population-wide screening for presymptomatic early-stage type 1 diabetes on paediatric clinical care |
Ezio Bonifacio, Christiane Winkler, Peter Achenbach, Anette-Gabriele Ziegler |
|
| 2024-05-22 |
[Corrections] Correction to Lancet Diabetes Endocrinol 2024; 12: 233–46 |
|
|
| 2024-05-22 |
[Corrections] Correction to Lancet Diabetes Endocrinol 2024; 12: 301–02 |
|
|
| 2024-05-22 |
[Articles] Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studies |
Yanping Li, Tianyi Huang, Susan Redline, Walter C Willett, JoAnn E Manson, Eva S Schernhammer, Frank B Hu |
|
| 2024-05-22 |
[Comment] Melatonin: is it really a cardiovascular wonder pill for shift workers? |
Pei Xue, Diana A Nôga, Christian Benedict |
|
| 2024-05-22 |
[Articles] Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial |
Christian L Roth, Cecilia Scimia, Ashley H Shoemaker, Michael Gottschalk, Jennifer Miller, Guojun Yuan, Sonali Malhotra, M Jennifer Abuzzahab |
|
| 2024-05-22 |
[Articles] Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial |
Katrien Benhalima, Kaat Beunen, Nancy Van Wilder, Dominique Ballaux, Gerd Vanhaverbeke, Youri Taes, Xavier-Philippe Aers, Frank Nobels, Joke Marlier, Dahae Lee, Joke Cuypers, Vanessa Preumont, Sarah E Siegelaar, Rebecca C Painter, Annouschka Laenen, Piete |
|
| 2024-05-22 |
[Comment] Demarcating the benefits of hybrid closed loop therapy in pregnant women with type 1 diabetes |
Helen R Murphy, Eleanor M Scott |
|
| 2024-05-22 |
[Comment] Setmelanotide: new promise for the treatment of hypothalamic obesity? |
Manuel Tena-Sempere |
|
| 2024-05-22 |
[Comment] Bone mineral density as a surrogate endpoint for fracture risk reduction in clinical trials of osteoporosis therapies: an update on SABRE |
Dennis M Black, Austin R Thompson, Richard Eastell, Mary L Bouxsein |
|
| 2024-05-22 |
[Correspondence] Improving support for university students with type 1 diabetes |
Gijsbert Stoet, Emily Foster, Catherine Kerr, Lingqing Jiang, Megan-Ann Thornhill, Katarzyna Cyranka, Bartłomiej Matejko, Dominika Sarna-Palacz, Magdalena Płonka-Stępień, Tomasz Klupa |
|
| 2024-04-24 |
[Comment] Endpoints for clinical trials in type 1 diabetes drug development |
Alfonso Galderisi, Brynn E Marks, Linda A DiMeglio, Carine de Beaufort |
|
| 2024-04-24 |
[Correspondence] Vitamin D supplements and future fracture risk among Mongolian schoolchildren |
Ning Ma, Xia Cui, Wenquan Niu |
|
| 2024-04-24 |
[Comment] The Human Insulin Thermal Solution project—a private sector initiative to address the thermostability of insulin |
Mats Rasmussen, Morten Hach, Jørgen Iwersen, Gayathri Anil, Henrik Rosborg, Jens Larsen, Lise Camilla Hoffmann, Peter Kurtzhals |
|
| 2024-04-24 |
[Correspondence] Environmental chemical obesogens, what can we do? |
Tim Lobstein |
|
| 2024-04-24 |
[Comment] Food additive emulsifiers: a new risk factor for type 2 diabetes? |
Mengxi Du, Frank B Hu |
|
| 2024-04-24 |
[In Focus] Anand Hardikar: a scientific nomad searching for the truth |
Susan Rahimi, Marta Koch |
|
| 2024-04-24 |
[Articles] Food additive emulsifiers and the risk of type 2 diabetes: analysis of data from the NutriNet-Santé prospective cohort study |
Clara Salame, Guillaume Javaux, Laury Sellem, Emilie Viennois, Fabien Szabo de Edelenyi, Cédric Agaësse, Alexandre De Sa, Inge Huybrechts, Fabrice Pierre, Xavier Coumoul, Chantal Julia, Emmanuelle Kesse-Guyot, Benjamin Allès, Léopold K Fezeu, Serge Hercbe |
|
| 2024-04-24 |
[Correspondence] Rethinking the label anti-obesity medication |
Stuart W Flint |
|
| 2024-04-24 |
[Correspondence] Vitamin D supplements and future fracture risk among Mongolian schoolchildren – Author's reply |
Adrian R Martineau, Polyna Khudyakov, Davaasambuu Ganmaa |
|
| 2024-04-24 |
[Editorial] Earth Day: time for transformational change |
The Lancet Diabetes & Endocrinology |
|
| 2024-04-24 |
[Review] Endocrine health in survivors of adult-onset cancer |
Cornelia S Link-Rachner, Andy Göbel, Nikolai P Jaschke, Tilman D Rachner |
|
| 2024-04-24 |
[Articles] Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127 594 people from 20 countries (PURE): a prospective cohort study |
Victoria Miller, David A Jenkins, Mahshid Dehghan, Kristie Srichaikul, Sumathy Rangarajan, Andrew Mente, Viswanathan Mohan, Sumathi Swaminathan, Rosnah Ismail, Maria Luz Diaz, Rekha M Ravindran, Katarzyna Zatonska, Ahmad Bahonar, Yuksel Altuntas, Rasha Kh |
|
| 2024-04-24 |
[Comment] Glycaemic index as part of the diabetes prevention strategy |
Gary Frost |
|
| 2024-04-24 |
[In Focus] Direct-to-consumer services: improving access to care for people with diabetes and obesity |
Talha Burki |
|
| 2024-04-24 |
[Articles] Familial aggregation and heritability of childhood-onset and adult-onset type 1 diabetes: a Swedish register-based cohort study |
Yuxia Wei, Shengxin Liu, Tomas Andersson, Maria Feychting, Ralf Kuja-Halkola, Sofia Carlsson |
|
| 2024-04-24 |
[Comment] Type 1 diabetes: heterogeneity in heritability |
Richard David Leslie |
|
| 2024-04-24 |
[Articles] Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis |
Cholesterol Treatment Trialists’ (CTT) Collaboration |
|
| 2024-04-24 |
[Comment] How clinically relevant is statin-induced diabetes? |
Hertzel C Gerstein, Marie Pigeyre |
|
| 2024-04-24 |
[Comment] Disparities in fragility fracture and osteoporosis care in Africa |
Kate A Ward, Tafadzwa Madanhire, Kebba Marenah, Lisa K Micklesfield, Celia L Gregson |
|
